<DOC>
	<DOCNO>NCT00900237</DOCNO>
	<brief_summary>This purpose study measure concentration two anti-epileptic drug ( Eslicarbazepine acetate oxcarbazepine ) metabolites cerebrospinal fluid blood plasma healthy subject also assess drug tolerate .</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetics Tolerability Multiple Doses Eslicarbazepine Acetate Oxcarbazepine</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Eslicarbazepine acetate</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Healthy subject Aged 1855 year Body mass index ( 18.529 kg/m3 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Partial</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Eslicarbazepine acetate</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Tolerability</keyword>
</DOC>